Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Break-through Infection Following Mpox vaccinatIon: Target Trial Emulation

NCT05522296 is registered in ClinicalTrials.gov with Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia as lead sponsor.

NCT NCT05522296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05522296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Break-through Infection Following Mpox vaccinatIon: Target Trial Emulation
Lead sponsor
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Phase
Observational
Overall status
Completed
Start date
September 12, 2022
Completion date
March 30, 2024
Enrollment
3,125 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

mpox